EMEA-002531-PIP01-18

Key facts

Active substance
  • Ramipril
  • bisoprolol
Therapeutic area
Cardiovascular diseases
Decision number
P/0212/2019
PIP number
EMEA-002531-PIP01-18
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
  • Treatment of coronary artery disease
  • Treatment of heart failure
  • Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Midas Pharma GmbH

E-mail: pv@midas-pharma.com
Tel. +49 6132 990583

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating